COHgb levels predict the long-term development of acute myocardial infarction in CO poisoning

Hakki Kaya1, Abuzer Coşkun2, Osman Beton1

  • 1Department of Cardiology, Cumhuriyet University Medical School, Sivas, Turkey.

Insights

High carboxyhemoglobin (COHb) levels after carbon monoxide (CO) poisoning predict long-term acute myocardial infarction (AMI) risk. Elevated COHb levels can help stratify patients for long-term AMI development after CO poisoning.

Area of Science:

  • Cardiology
  • Toxicology
  • Epidemiology

Background:

  • Limited research exists on long-term cardiac effects of carbon monoxide (CO) poisoning.
  • Studies primarily focus on acute cardiac effects, necessitating investigation into chronic outcomes.

Purpose of the Study:

  • To evaluate the association between blood carboxyhemoglobin (COHb) levels and the long-term risk of acute myocardial infarction (AMI) following CO poisoning.
  • To determine if initial COHb levels can predict future cardiac events.

Main Methods:

  • A cross-sectional cohort study of 1013 patients with CO poisoning was conducted.
  • Patients were followed for an average of 56 months to track AMI development.
  • Diagnosis of CO poisoning required a COHb level >5%.

Main Results:

  • 10% of patients developed AMI during follow-up.
  • Higher initial COHb levels were significantly associated with AMI development (55%±6% vs 30%±7%, P<.001).
  • Age, COHb level, CO exposure time, and smoking were independent predictors of AMI risk. A COHb cutoff of >45% predicted AMI with 98% sensitivity and 94.1% specificity.

Conclusions:

  • Blood carboxyhemoglobin levels are valuable for stratifying long-term AMI risk in patients with CO poisoning.
  • Higher COHb levels indicate a greater risk for developing AMI post-poisoning.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
690
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
736
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671